SciELO - Scientific Electronic Library Online

 
vol.22 número4Factores que interfieren los cribados para cánceres ginecológicos en mujeres peruanasAsociación entre ansiedad y depresión en estudiantes de Medicina de la Universidad Ricardo Palma durante el año 2021 índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista de la Facultad de Medicina Humana

versión impresa ISSN 1814-5469versión On-line ISSN 2308-0531

Rev. Fac. Med. Hum. vol.22 no.4 Lima oct./dic. 2022  Epub 12-Oct-2022

http://dx.doi.org/10.25176/rfmh.v22i4.5115 

Original article

MAYTENUS MACROCARPA “Chuchuhuasi” decrease the fertility and sperm quality in mice

Jonathan Vásquez Cavero1  2  , Biólogist

Pilar Pino Velásquez1  , Biólogist, Master in Assisted Reproduction Procedures

José Gonzáles Daga1  , Biólogist, Master in Molecular Biology

Eduardo Pulido-Murillo3  , Clinical pathologist

José Pino Gaviño1  , Biólogist

1Laboratorio de Reproducción y Biología del Desarrollo. Facultad de Ciencias Biológicas. Universidad Nacional Mayor de San Marcos. Lima-Perú.

2Laboratorio de Fisiología de la Reproducción Animal. Facultad de Ciencias Biológicas. Universidad Nacional Mayor de San Marcos. Lima-Perú.

3Instituto de investigaciones en ciencias biomédicas. Facultad de medicina humana. Universidad Ricardo Palma. Lima, Perú.

ABSTRACT

Introduction:

Maytenus macrocarpa (MM) "Chuchuhuasi" is a native plant from the Amazon region of South America, widely used in traditional medicine due its anti-inflammatory, analgesic and anti-tumor properties. However, its effects on reproductive physiology and male fertility have not been elucidated.

Methods:

Preclinical experimental study of cases and controls. Male mice with eight weeks from birth were administered orally for 70 days (two spermatogenic cycles) an aqueous extract MM: GC (n = 8) 0 mg / kg body weight (bw) control group and treated group GT (n = 8) 1000 mg / kg bw. Later the animals were euthanized, the reproductive organs were weighted, also motility and sperm count were recorded. During the days 60 or 65 of treatment, males were mated and pregnant females were sacrificed in the fourth day of pregnancy for evaluating development, quality and degree of blastulation.

Results:

The weights of reproductive organs did not differ significantly between the two groups (p> 0.05). However, progressive motility (32.81 vs. 15.27 ± 4.17% ± 2.08%) and sperm count (7.75 ± 0.34 x 106 / ml vs. 2.56 ± 0.42 x 106 / ml) decreased significantly between GC and GT, respectively. 87.5% (7/8) of the pregnant mice produced 15 litters (GC) and only 50% (4/8) of the pregnant GT yields 4 litters. However, no significant differences were found in the percentage of blastocyst stage embryos, good quality embryos, or embryos with greater than 50% the size of the embryo between the two groups (p> 0.05) blastoceles.

Conclusion:

the aqueous extract of Maytenus macrocarpa (1000 mg/kl) could have possesses anti-reproductive action in male mice.

Keywords: parameters; embryos classification; aqueous extract; fertility; Maytenus macrocarpa (Source: MeSH NLM).

INTRODUCTION

Plants and their active compounds have been used as an important source of medicines to treat various diseases. The therapeutic potential of most of these plants is based on their anti-cancer, anti-diabetic, hepatoprotective, cardioprotective, analgesic, and other pharmacological properties1. However, some plants may adversely affect different physiological functions, including male reproductive function, whose adverse effects have been attributed mainly to anti-spermatogenic and anti-steroidogenic properties of one or more active compounds.2-5We should consider the importance of the study of medicinal plants because approximately 75-80% of the world's population consumes them6and in Peru 1400 species of plants are used for medicinal purposes, whose widespread use has been recorded for thousands of years7.

Celastraceae is a large family of trees and shrubs, there are approximately 89 genera and 1300 species that have been used for centuries for the treatment of stomach complications, fever, rheumatism, and cancer8. The Celastraceae family is recognized in Peru for having eight genera and 29 species9and Maytenus is one of the largest genera10and its plants are used in traditional medicine in South America as infusions11. The metabolites of the genus Maytenus are mainly tripertenos12,13and flavonoids.14The biological activity of several Maytenus species has been demonstrated: M. ilicifolia as a contraceptive, anti-inflammatory and antioxidant15,16; M. krukovii presents antioxidant, antimutagenic and antimicrobial activity17; M. aquifolium, analgesic properties18; M. senegalensis has antibacterial, antiviral, antitumor activity19,20,21and M. macrocarpa acts as a cytotoxic22and antimicrobial agent23.

Maytenus macrocarpa Ruiz and Pav. (Chuchuhuasi) is a native plant of the Amazonian region of Peru, its bark is generally used as an aguardiente for the treatment of rheumatism, influenza, and gastrointestinal diseases and as an antitumor agent24. There is scarce information on the effects of plants of the genus Maytenus on the reproductive system in mammals; Montanari et al.,25provided daily doses of 800 mg/kg bw of the ethanolic extract of M. ilicifolia to mice and microscopic analysis of the seminiferous tubules showed no abnormalities. However, at daily doses of 1000 mg/kg bw the hydroalcoholic extract of M. ilicifolia interfered negatively with embryonic implantation in mice.

The present study aims to evaluate the implications of Maytenus macrocarpa aqueous extract (1000 mg/kg bw) intake during 2 spermatogenic cycles (70 days) on reproductive parameters and fertility in mice.

METHODS

Design and study area

Preclinical experimental case-control study, experimental biology area.

Population and sample

The sample consisted of 20 male mice (Mus musculus) of the BALB/c strain of 8-10 weeks of age, the case (experimental) group consisted of 10 mice, which were administered aqueous extract through nasogastric tube N°18 (Fisher Scientific, Pittsburgh, PA, USA), at a concentration of 1000 mg/kg body weight for 70 days. The control group consisted of 10 mice that received distilled water by the same route. All were kept in a temperature-controlled room (22-25°C) with 14/10 h light/dark cycles, and water and mouse chow were provided ad libitum.

Variables

Independent variables: Sex (male, female, treatment male mice, pregnant females day 1 and day 4, weight pregnant females day 1 and day 4, presence of corpus luteum, number of embryos, embryo grade, embryo stage.

Dependent variables: reproductive quality of the male mouse, preimplantation embryonic development. A data collection form was made with all the variables of the research study where the findings were recorded.

Procedures

1. Preparation of aqueous extract: Maytenus macrocarpa was purchased from PromoAgro export SAC (Lima, Peru). The aqueous extract was prepared from the dried and powdered material of the bark. 100 g of Chuchuhuasi was heated (90-100 °C) for 30 minutes in 1 L of water. It was then cooled at room temperature overnight and the next day the supernatant was filtered twice with sterile Whatman filter paper (40µm and 20 µm) until a paste was obtained. The paste was dissolved in distilled water. The final volume of the extract (100 mg-ml ) was aliquoted into 1.5 ml vials and stored at 4° C until use.

2. Treatment: Mice were divided into two groups; the Treatment Group (TG) (n=10) was administered Maytenus macrocarpa aqueous extract (1000 mg/kg bw) and the Control Group (CG) (n=10) was administered distilled water (vehicle) for 70 days. The aqueous extract of M. macrocarpa and distilled water were administered using an esophageal probe N°18 (Fisher Scientific, Pittsburgh, PA, USA). Body weight was recorded every 7 days and after treatment the animals were euthanized by cervical dislocation. The weight of the reproductive organs: testes, epididymis and prostate were recorded using an analytical balance with 0.001 g sensitivity. Spermatozoa were obtained from the tail of the epididymis and sperm motility and concentration were analyzed according to WHO (2010).

3. Obtaining epididymis and spermatozoa: Each of the epididymides obtained were washed with phosphate-buffered saline (PBS pH 7.4) at 37°C, several cuts were made in the tail of the epididymis and then the spermatozoa were released for 10 minutes in 0.5 ml of Flushing culture medium (MediCult®, Copenhagen, Denmark), the sperm content was recovered in its entirety in 1.5 ml polypropylene tubes (Axygen Scientific).

4. Evaluation of sperm motility: A drop of sperm sample (10 ul) was placed on a slide at 37°C in an incubator with CO2 and directly observed at 400 X in a phase contrast microscope (AJ Seitz, San Francisco, U.S.A). This procedure was performed twice, the results presented are the average of both evaluations, being evaluated at least 200 spermatozoa. Spermatozoa were considered to have Progressive Mobility (PM) when they moved, Non-Progressive Mobility (NPM) when they did not move and only had an in situ movement, and Immotile (I) when they did not show any type of movement6.

5. Fertility: During days 60-65 of treatment, 01 male mouse was placed at night (20:00-21:00 hours) with two six-week-old virgin females in estrus or estrus phase during the whole night and the following morning (9:00-10:00 hours) the presence or absence of the vaginal plug was visualized, the presence of the vaginal plug was considered as day 1 of pregnancy. The pregnant mice were sacrificed on the fourth day of gestation, then the uterine horns and oviducts were perfused, and the embryos were recovered to evaluate: development, quality and degree of blastulation.

6. btaining and evaluation of preimplantation embryos: Mice 4 days pregnant were euthanized by cervical dislocation. The uterine horns and oviducts were dissected to obtain and evaluate their embryos and the ovaries were dissected to count corpora lutea.

7. Embryo evaluation: Uterine horns and oviducts were perfused with Flushing culture medium (MediCult®, Copenhagen, Denmark), to obtain embryos. Subsequently, embryo development, embryo quality and degree of blastulation were evaluated.

8. Embryo development: They were classified according to the stage of preimplantational embryonic development26:

  • Delayed stage: Less than 9 cells per embryo.

  • Morula: More than 8 cells with signs of compaction.

  • Blastocyst stage: More than 32 compact cells and the presence of blastocele.

9. Embryo quality: An embryo grading system proposed by Dorn & Kramer27 and subsequently described by Dawson et al.26) . This method classifies embryos into four different categories:

  • Grade I: The embryo shows homogeneous, symmetrical blastomeres without fragmentation.

  • Grade II: The embryo presents some free blastomeres and some fragments of cytoplasm may be present.

  • Grade III: The embryo presents free, asymmetric blastomeres with severe malformations.

  • Grade IV or degenerated: The embryo is bowl-shaped, almost no defined blastomeres are observed and the cell membrane is broken.

10. Blastulation grade: According to the size of the blastocele, embryos were classified as follows:

  • Initial Blastocyst: Blastocele occupies less than 30% of the embryo size.

  • Intermediate Blastocyst: Blastocele occupies between 30% and 50% of the embryo size.

  • Advanced Blastocyst: Blastocele occupies between 50% and 90% of the embryo size.

  • Expanded Blastocyst: Blastocele occupies more than 90% of the embryo size.

Statiscal Analysis

The homoscedasticity (equality of variances) of the data was tested using Levene's test. To check whether the data obtained for the different variables to be evaluated were normally distributed, the Shapiro-Wilk test was performed. When the variable to be evaluated had a normal distribution, the means were compared with t-Student, otherwise, the Mann-Whitney U test was applied for nonparametric tests. The results were expressed as mean ± SE (standard error). The SPSS Ver 17.00 statistical program was used, considering a significance level of p≤ 0.05.

Ethical aspects

Animal care and handling were performed in accordance with the ethical guidelines of our institution.

RESULTS

Body weight and reproductive organs

No significant differences were observed in the increase in body weight, testicular, epididymal, vas deferens and prostate weight (p>0.05) between the two groups. The results are summarized inTable 1.

Table 1.  Bodyand reproductive organ weights. 

  CG TG
n 8 8
Weight left testicle 0,1066 ± 0,0054 0,1180 ± 0,0058
Left epididymal weight 0,0401 ± 0,0012 0,0410 ± 0,0013
Weight of left vas deferens 0,0133 ± 0,0010 0,0137 ± 0,0030
Weight right testicle 0,1121 ± 0,0046 0,1239 ± 0,0062
Right epididymal weight 0,0413 ± 0,0012 0,0424 ± 0,0014
Right vas deferens weight 0,0138 ± 0,0010 0,0138 ± 0,0005
Weight Prostate 0,0513 ± 0,0022 0,0428 ± 0,0029

CG: Control group 0 mg/kg MM and TG: Treated group 1000 mg/kg MM. Mean ± ES; analyzed by t-Student.

Sperm motility and concentration

In the WG with respect to the CG, PM was significantly decreased (15.27 ± 2.08 vs. 32.81 ± 4.17, p<0.05) and immotile spermatozoa were significantly increased (69.25 ± 4.17 vs. 50.05 ± 3.77, p<0.05). NPM was not altered (17.14 ± 3.48 vs. 15.48 ± 3.09, p>0.05) between both groups.Figure 1.

Figure 1 Sperm motility in both groups (WHO 2010). PM = Progressive motility, NPM = Non-Progressive motility and I = Immotile. * Indicates statistically significant difference (p<0.05) after t-Student analysis. 

Regarding sperm concentration in the epididymal tail, it decreased in the TG with respect to the CG (2.56 ± 0.42 vs. 7.75 ± 0.34, p<0.05).Figure 2.

Figure 2 Sperm concentration in both groups. * Indicates statistically significant difference (p<0.05) after t-Student analysis. ml = milliliter  

Fertility

Of the CG, 87.5% (7/8) of the males impregnated females and produced 15 litters and of the TG, only 50% (4/8) of the males impregnated females and produced four litters (Table 2).

Table 2.  Fertility evaluation in both groups. 

  CG TG
Fertility 87,5 (7/8) 50,0 (4/8)
Pregnant Females 15 4
Embryos per Litter 9,27 ± 0,66 9,75 ± 1,11

CG: Control group 0 mg/kg MM and GT: Treated group 1000 mg/kg MM. Mean ± EE.

Evaluations of pregnant females are summarized inTable 3.

Table 3.  Characteristics of the females. 

  CG TG
Number of females evaluated 15 4
Total number of embryos analyzed 139 39
Number of corpora lutea 10,26 ± 0,50 11,25 ± 0,85
Number of embryos per litter 9,26 ± 0,65 9,75 ± 1,10

CG: Control group 0 mg/kg MM and TG: Treated group 1000 mg/kg MM. Mean ± ES; analyzed by t-Student.

Although the aqueous extract of Maytenus macrocarpa decreased fertility because fewer males became pregnant (Table 2 and Table 3), the quality, development and degree of blastulation did not differ between the two groups (Figure 3, 4 and 5).

Regarding the embryos obtained, no significant differences were found in the percentage of blastocysts (79.69 ± 5.25 % vs. 75.23 ± 12.00 %), morulae (15.42 ± 4.30 % vs. 20.61 ± 9.55 %) and embryos with less than 9 cells (4.87 ± 2.40 % vs. 4.17 ± 1.35 %) between GC and GT, respectively (p'0.05) (Figure 3).

Figure 3 Embryonic development. GC: Control group 0 mg/kg MM and GT: Treated group 1000 mg/kg MM. Mean ± ES; analyzed by Mann-Whitney U test 

No significant differences were found in the percentage of grade I (80.64 ± 5.28 % vs. 79.40 ± 9.55 %), grade II (8.63 ± 2.36 % vs. 10.61 ± 7.87 %), grade III (2.96 ± 2.96 % vs. 10.00 ± 10.00 %) and grade IV or degenerated (7.76 ± 3.69 % vs. 0.00 ± 0.00 %) embryos between GC and GT, respectively (p'0.05) (Figure 4).

Figure 4 Embryo grading. CG: Control group 0 mg/kg MM and TG: Treated group 1000 mg/kg MM. Mean ± ES; analyzed by Mann-Whitney U test 

No significant differences were found in the percentage of blastocysts: initial (16.29 ± 5.82 % vs. 14.91 ± 3.61 %), intermediate (14.72 ± 4.40 % vs. 7.27 ± 4.75 %), advanced (35.63 ± 5.08 % vs. 31.77 ± 8.62 %) and expanded (13.05 ± 4.24 % vs. 21.28 ± 12.00 %) blastocysts (p'0.05) (Figure 5).

Figure 5:  Degree of embryo blastulation. GC: Control group 0 mg/kg MM and GT: Treated group 1000 mg/kg MM. Mean ± ES; analyzed by Mann-Whitney U test. 

DISCUSSION

The present study investigated the effect of Maytenus macrocarpa on reproductive parameters and fertility in mice. The use of some plants as male contraceptives has been postulated2,3,5, and should exert a localized effect at the level of the reproductive system, and not a systemic effect that may alter other physiological functions.28,29,30The present work suggests the direct action of Maytenus macrocarpa on the reproductive system because there is no modification of body weight (Table 1, p>0.05), while the values of sperm motility and concentration decreased (Figure 1and 2, respectively, p<0.05), and fertility also decreased after treatment with Maytenus macrocarpa (Table 2). The testes, epididymis, and prostate are androgen-dependent organs31, we did not observe any modification of their weights, so Maytenus macrocarpa would not be exerting an anti-androgenic effect on the male reproductive system32.

Maytenus species possess a large amount of phenolic metabolites such as triterpenes12,13and flavonoids14, justifying their potent anti-inflammatory action33,34. Based on our results, it is suggested that these molecules could be responsible for the decrease in reproductive parameters as it has been reported that triterpene molecules strongly inhibit sperm motility35and stop spermatogenesis in rats36as well as having a potent inhibitory effect on prostaglandin E237; this lipid molecule is of great importance on sperm motility38by increasing it39, it also induces the entry of calcium into the spermatozoon prior to the acrosomal reaction40. In turn, flavonoids have been shown to inhibit sperm motility35and acrosomal activity41. Nor-triterpenes known as macrocarpins have also been reported in Maytenus macrocarpa which possesses strong cytotoxic activity22, so these molecules could also be responsible for the decrease in reproductive characteristics after ingestion of Maytenus macrocarpa.

In contrast to our results, Montanari et al.24observed through histological sections of mouse testes, that the ingestion of daily doses of 800 mg/kg bw of the ethanolic extract of M. ilicifolia for 30 days did not alter spermatogenesis, which could indicate that the action of Maytenus macrocarpa could be at the post-testicular level, that is, during the transit of spermatozoa through the epididymis. Other possibilities are that the effect of the plants of the genus Maytenus is species-specific and/or specific to the type of extract used, as different types of action have been reported in other plants according to the extract used42. Since we used an aqueous extract and Montanari et al24an ethanolic extract, we suggest that one or more highly polar compounds may be responsible for the anti-reproductive effects observed.

The dosage time (30 days) used by Montanari et al.24would not be the reason why no effects on spermatogenesis were observed because in a previous work43we observed that the intake for only 7 days of Maytenus macrocarpa decreased sperm quality in mice, this would support our observation that Maytenus macrocarpa would exert its effect on spermiation and transport in the epididymis because these phenomena occur in a period of 7 days44.

While sperm cytoplasmic deficiencies can be detected as early as in a one-cell embryo45, deficiencies occurring at the genomic level of the sperm cannot be detected in the embryo before the 8-cell stage of embryo development46,47, because of this, we decided to evaluate the blastocyst stage embryo. We found a relationship between the genetic integrity of the spermatozoon and cleavage during the embryo development process48,49and the absence of negative effects in the blastocyst stages of the Treatment Group corresponding to pregnant females which could indicate that the ingestion of the aqueous extract of M. macrocarpa does not affect the genetic integrity of the spermatozoon, allowing a normal embryonic development. These results are in agreement with previous studies where there is no toxic effect on species of the genus Maytenus50,52, on the other hand, antimutagenic properties have been reported in the genus Maytenus.17

Many plant contraceptives act by decreasing sperm motility and concentration in the tail of the epididymis28,29, characteristics of great importance for reproductive success(53), as observed with the aqueous extract of Maytenus macrocarpa.

The limitations of the study were mainly of an institutional logistical nature, such as power outages or untimely closure of the university, which prevented dosing or evaluation at the agreed time, having to repeat the entire dosing process.

CONCLUSION

The ingestion of Maytenus macrocarpa aqueous extract could decrease sperm motility and concentration, as well as fertility in mice. As for the embryos obtained, no significant differences were found between the stages studied. It is evident that further studies are needed to identify which compounds would be responsible for its anti-reproductive effects.

REFERENCES

1. D&apos;Cruz SC, Vaithinathan S, Jubendradass R, Mathur PP. Effects of plants and plant products on the testis. Asian J Androl. 2010;12:468-79. DOI: 10.1038/aja.2010.43. [ Links ]

2. Ashok P, Meenakshi B. Contraceptive effect of Curcuma longa (L.) in male albino rat. Asian J Androl. 2004; 6:71-4.https://pubmed.ncbi.nlm.nih.gov/15064838/. [ Links ]

3. Gupta RS, Kachhawa JB, Chaudhary R. Antifertility effects of methanolic pod extract of Albizzia lebbeck (L.) Benth in male rats. Asian J Androl. 2004;6:155-9. https://pubmed.ncbi.nlm.nih.gov/15154091/. [ Links ]

4. Lohiya NK, Manivannan B, Mishra PK, et al. Chloroform extract of Carica papaya seeds induces long-term reversible azoospermia in langur monkey. Asian J Androl. 2002;4:17-26. https://pubmed.ncbi.nlm.nih.gov/11907624/. [ Links ]

5. Gupta RS, Sharma RA. A review on medicinal plants exhibiting antifertility activity in males. Nat Prod Radiance. 2006;5:389-410. http://nopr.niscpr.res.in/bitstream/123456789/8007/1/NPR%205%285%29%20389-410.pdfLinks ]

6. World Health Organization. WHO laboratory manual for the examination and processing of human semen. 5th ed. Geneva: World Health Organization; 2010.https://apps.who.int/iris/handle/10665/44261. [ Links ]

7. Palacios EE. Economía y plantas medicinales. UNMSM CSI Boletín. 2004;52:28-31. https://sisbib.unmsm.edu.pe/bibvirtualdata/publicaciones/consejo/boletin52/Pdf/a04.pdf . [ Links ]

8. Mejia K, Rengifo E. Plantas Medicinales de uso popular en la Amazonía Peruana. Lima: Instituto de Investigación de la Amazonía Peruana - Gobierno Regional de Loreto - Agencia Española de Cooperación Internacional, 2ª ed., 2000. 286 págs. ISBN: 9972-614-00-5. https://www.fitoterapia.net/publicaciones/documentacion/protective-effect-ispirulina-maximai-male-302.html. [ Links ]

9. León B. Celastraceae endémicas del Perú. Rev peru biol. 2006;13:255.http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1727-99332006000200035. [ Links ]

10. Stevens AM. ANGIOSPERM PHYLOGENY WEBSITE, version 12. http://www.mobot.org/MOBOT/research/APweb/. [ Links ]

11. Bueno NR, Castilho RO, Costa RBd, et al. Medicinal plants used by the Kaiowá and Guarani indigenous populations in the Caarapó Reserve, Mato Grosso do Sul, Brazil. Acta Botanica Brasilica. 2005;19:39-44. 10.1590/S0102-33062005000100005 [ Links ]

12. Itokawa H, Shirota O, Ikuta H, Morita H, Takeya K, Iitaka Y. Triterpenes from Maytenus ilicifolia. Phytochemistry. 1991;30:3713-6.10.1016/0031-9422(91)80096-J. [ Links ]

13. Shirota O, Morita H, Takeya K, Itokawa H. Cytotoxic aromatic triterpenes from Maytenus ilicifolia and Maytenus chuchuhuasca. J Nat Prod. 1994;57:1675-81. doi:10.1021/np50114a009. [ Links ]

14. Leite JP, Rastrelli L, Romussi G, et al. Isolation and HPLC quantitative analysis of flavonoid glycosides from Brazilian beverages (Maytenus ilicifolia and M. aquifolium). J Agric Food Chem. 2001;49:3796-801. DOI: 10.1021/jf010294n. [ Links ]

15. Jorge RM, Leite JP, Oliveira AB, Tagliati CA. Evaluation of antinociceptive, anti-inflammatory and antiulcerogenic activities of Maytenus ilicifolia. J Ethnopharmacol. 2004;94:93-100.10.1016/j.jep.2004.04.019. [ Links ]

16. Vellosa JC, Khalil NM, Formenton VA, et al. Antioxidant activity of Maytenus ilicifolia root bark. Fitoterapia. 2006;77:243-4. DOI:10.1016/j.fitote.2006.02.007. [ Links ]

17. Bruni R, Rossi D, Muzzoli M, et al. Antimutagenic, antioxidant and antimicrobial properties of Maytenus krukovii bark. Fitoterapia. 2006;77:538-45.DOI:10.1016/j.fitote.2006.06.009. [ Links ]

18. Gonzalez FG, Portela TY, Stipp EJ, Di Stasi LC. Antiulcerogenic and analgesic effects of Maytenus aquifolium, Sorocea bomplandii and Zolernia ilicifolia. J Ethnopharmacol. 2001;77:41-7.10.1016/S0378-8741(01)00268-9. [ Links ]

19. Gessler MC, Tanner M, Chollet J, Nkunya MHH, Heinrich M. Tanzanian medicinal plants used traditionally for the treatment of malaria: In vivo antimalarial and in vitro cytotoxic activities. Phytotherapy Research. 1995;9:504-8. DOI:10.1002/ptr.2650090708. [ Links ]

20. Otake T, Mori H, Morimoto M, et al. Screening of Indonesian plant extracts for anti-human immunodeficiency virus-type 1 (HIV-1) activity. Phytotherapy Research. 1995;9:6-10. 10.1002/ptr.2650090103. [ Links ]

21. Matu EN, van Staden J. Antibacterial and anti-inflammatory activities of some plants used for medicinal purposes in Kenya. J Ethnopharmacol. 2003;87:35-41. DOI:10.1016/s0378-8741(03)00107-7. [ Links ]

22. Chavez H, Rodriguez G, Estevez-Braun A, et al. Macrocarpins A-D, new cytotoxic nor-triterpenes from Maytenus macrocarpa. Bioorg Med Chem Lett. 2000;10:759-62. DOI:10.1016/s0960-894x(00)00082-2. [ Links ]

23. Kloucek P, Svobodova B, Polesny Z, Langrova I, Smrcek S, Kokoska L. Antimicrobial activity of some medicinal barks used in Peruvian Amazon. J Ethnopharmacol. 2007;111:427-9.10.1016/j.jep.2006.11.010 [ Links ]

24. Montanari T, de Carvalho JE, Dolder H. Effect of Maytenus ilicifolia Mart.ex. Reiss on spermatogenesis. Contraception. 1998;57:335-9. DOI:10.1016/s0010-7824(98)00038-9. [ Links ]

25. Montanari T, Bevilacqua E. Effect of Maytenus ilicifolia Mart. on pregnant mice. Contraception. 2002;65:171-5. DOI:10.1016/S0010-7824(01)00301-8. [ Links ]

26. Dawson KJ, Conaghan J, Ostera GR, Winston RM, Hardy K. Delaying transfer to the third day post-insemination, to select non-arrested embryos, increases development to the fetal heart stage. Hum Reprod. 1995;10:177-82. DOI: 10.1093/humrep/10.1.177. [ Links ]

27. Dorn CG, Kraemer DC. Bovine embryo grading. Texas: Texas A & M University; 1987. ... [ Links ]

28. Sharma N, Jocob D. Antifertility investigation and toxicological screening of the petroleum ether extract of the leaves of Mentha arvensis L. in male albino mice. J Ethnopharmacol. 2001;75:5-12. DOI: 10.1016/S0378-8741(00)00362-7. [ Links ]

29. Venma PK, Sharma A, Mathur A, et al. Effect of Sarcostemma acidum stem extract on spermatogenesis in male albino rats. Asian J Androl. 2002;4:43-7.https://pubmed.ncbi.nlm.nih.gov/11907627/#:~:text=Results%3A%20S.,at%20the%20100%20mg%20dose. [ Links ]

30. Gupta RS, Kumar P, Dixit VP, Dobhal MP. Antifertility studies of the root extract of the Barleria prionitis Linn in male albino rats with special reference to testicular cell population dynamics. J Ethnopharmacol. 2000;70:111-7. DOI: 10.1016/s0378-8741(99)00150-6. [ Links ]

31. Trentacoste SV, Friedmann AS, Youker RT, Breckenridge CB, Zirkin BR. Atrazine effects on testosterone levels and androgen-dependent reproductive organs in peripubertal male rats. J Androl. 2001;22:142-8.https://pubmed.ncbi.nlm.nih.gov/11191080/Links ]

32. Manivannan B, Mittal R, Goyal S, Ansari AS, Lohiya NK. Sperm characteristics and ultrastructure of testes of rats after long-term treatment with the methanol subfraction of Carica papaya seeds. Asian J Androl. 2009;11:583-99. doi: 10.1038/aja.2009.25 [ Links ]

33. Santos VLd, Costa VBM, Agra MdF, Silva BAd, Batista LM. Pharmacological studies of ethanolic extracts of Maytenus rigida Mart (Celastraceae) in animal models. Revista Brasileira de Farmacognosia. 2007;17:336-42.doi.org/10.1590/S0102-695X2007000300006. [ Links ]

34. Gonzalez-Gallego J, Sanchez-Campos S, Tunon MJ. Anti-inflammatory properties of dietary flavonoids. Nutr Hosp. 2007;22:287-93. https://pubmed.ncbi.nlm.nih.gov/17612370/. [ Links ]

35. Chattopadhyay D, Dungdung SR, Mandal AB, Majumder GC. A potent sperm motility-inhibiting activity of bioflavonoids from an ethnomedicine of Onge, Alstonia macrophylla Wall ex A. DC, leaf extract. Contraception. 2005;71:372-8. doi.org/10.1016/j.contraception.2004.11.006. [ Links ]

36. Chaudhary R, Gupta RS, Kachhaw JBS, Singh D, Verma SK. Inhibition of Spermatogenesis by Triterpenes of Albizia lebbeck (L.) Benth Pods in Male Albino Rats 2007; 7:86-93. doi.org/10.18311/jnr/2007/199 [ Links ]

37. Reyes CP, Nunez MJ, Jimenez IA, Busserolles J, Alcaraz MJ, Bazzocchi IL. Activity of lupane triterpenoids from Maytenus species as inhibitors of nitric oxide and prostaglandin E2. Bioorg Med Chem. 2006;14:1573-9. DOI: 10.1016/j.bmc.2005.10.063. [ Links ]

38. Schlegel W, Rotermund S, Farber G, Nieschlag E. The influence of prostaglandins on sperm motility. Prostaglandins. 1981;21:87-99. DOI:doi.org/10.1016/0090-6980(81)90199-4 [ Links ]

39. Didolkar AK, Roychowdhury D. Effects of prostaglandins E-1, E-2, F-1a and F-2a on human sperm motility. Andrologia. 1980;12:135-40. DOI: 10.1111/j.1439-0272.1980.tb00597.x . [ Links ]

40. Shimizu Y, Yorimitsu A, Maruyama Y, Kubota T, Aso T, Bronson RA. Prostaglandins induce calcium influx in human spermatozoa. Mol Hum Reprod. 1998;4:555-61. DOI:10.1093/molehr/4.6.555. [ Links ]

41. Taitzoglou IA, Tsantarliotou M, Zervos I, Kouretas D, Kokolis NA. Inhibition of human and ovine acrosomal enzymes by tannic acid in vitro. Reproduction. 2001;121:131-7.https://pubmed.ncbi.nlm.nih.gov/11226036/Links ]

42. Aguilar JL, Rojas P, Marcelo A, et al. Anti-inflammatory activity of two different extracts of Uncaria tomentosa (Rubiaceae). J Ethnopharmacol. 2002;81:271-6. DOI: 10.1016/s0378-8741(02)00093-4 [ Links ]

43. Acosta L, Vasquez J, Núñez V, Pino J, Shiga B. Efecto de Maytenus macrocarpa "Chuchuhuasi" en el sistema reproductor masculino del ratón (Mus musculus). Revista Peruana de Biología 2014;20(3): 223-226. DOI: 10.15381/rpb.v20i3.5219 [ Links ]

44. Pina-Guzman B, Solis-Heredia MJ, Quintanilla-Vega B. Diazinon alters sperm chromatin structure in mice by phosphorylating nuclear protamines. Toxicol Appl Pharmacol. 2005;202:189-98. DOI:10.1016/j.taap.2004.06.028. [ Links ]

45. Tesarik J, Greco E, Mendoza C. Late, but not early, paternal effect on human embryo development is related to sperm DNA fragmentation. Hum Reprod. 2004;19:611-5. DOI: 10.1093/humrep/deh127. [ Links ]

46. Tesarik J. Paternal effects on cell division in the human preimplantation embryo. Reprod Biomed Online. 2005;10:370-5. DOI: 10.1016/S1472-6483(10)61798-1. [ Links ]

47. Vanderzwalmen P, Hiemer A, Rubner P, et al. Blastocyst development after sperm selection at high magnification is associated with size and number of nuclear vacuoles. Reprod Biomed Online. 2008;17:617-27. DOI:10.1016/s1472-6483(10)60308-2. [ Links ]

48. Aitken RJ, De Iuliis GN. Origins and consequences of DNA damage in male germ cells. Reprod Biomed Online. 2007;14:727-33. DOI: 10.1016/S1472-6483(10)60676-1 . [ Links ]

49. Seli E, Sakkas D. Spermatozoal nuclear determinants of reproductive outcome: implications for ART. Hum Reprod Update. 2005;11:337-49. DOI:10.1093/humupd/dmi011. [ Links ]

50. Camparoto ML, Teixeira RdO, Mantovani MS, Vicentini VEP. Effects of Maytenus ilicifolia Mart. and Bauhinia candicans Benth infusions on onion root-tip and rat bone-marrow cells. Genetics and Molecular Biology. 2002;25:85-9.https://www.scielo.br/j/gmb/a/F99FZPqXmTJYrP3BPmwHR9b/?format=pdf&lang=enLinks ]

51. Mota KSdL, Pita JCLR, Estevam EC, et al. Evaluation of the toxicity and antiulcerogenic activity of the ethanol extract of Maytenus obtusifolia Mart. leaves. Revista Brasileira de Farmacognosia. 2008;18:441-6. 10.1590/S0102-695X2008000300019. [ Links ]

52. da Silva G, Tanica M, Rocha J, et al. In vivo anti-inflammatory effect and toxicological screening of Maytenus heterophylla and Maytenus senegalensis extracts. Hum Exp Toxicol. 2011;30:693-700. DOI:10.1177/0960327110379242. [ Links ]

53. Bedford JM. Significance of the need for sperm capacitation before fertilization in eutherian mammals. Biol Reprod. 1983;28:108-20.https://agris.fao.org/agris-search/search.do?recordID=US201302615420. [ Links ]

Funding sources: Vicerrectorado de Investigación de la Universidad Nacional Mayor de San Marcos (Multidisciplinary Project Grant # PEM2008A02).

8 Article published by the Journal of the faculty of Human Medicine of the Ricardo Palma University. It is an open access article, distributed under the terms of the Creatvie Commons license: Creative Commons Attribution 4.0 International, CC BY 4.0(https://creativecommons.org/licenses/by/1.0/), that allows non-commercial use, distribution and reproduction in any medium, provided that the original work is duly cited. For commercial use, please contact revista.medicina@urp.edu.pe.

Received: May 06, 2022; Accepted: August 25, 2022

Correspondence: José Luis Rafael Pino Gaviño. Address: 375 German Amézaga Ave., Cercado Lima-Peru. Telephone number: 992169186 E-mail:jpinog@unmsm.edu.pe

Authorship contributions: The authors participated in the genesis of the idea, project design, development, data collection and interpretation, analysis of results, and preparation of the manuscript.

Conflicts of interest: The authors declare that they have no conflict of interest in the publication of this article.

Creative Commons License Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons